Oral ganciclovir as prophylaxis against cytomegalovirus.
Nicklin
D
D
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000284:Administration, Oral; D000380:Agranulocytosis / Q000139:chemically induced*; D003362:Cost-Benefit Analysis; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000009:adverse effects* / Q000191:economics; D006801:Humans
D015774:Ganciclovir